CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 876,020 | $31,037,000 | 13.97% |
| Private Capital Advisors, Inc. | 173,191 | $6,136,000 | 2.23% |
| ARDSLEY ADVISORY PARTNERS LP | 265,000 | $9,389,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 944,522 | $33,464,000 | 1.61% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 446,824 | $15,830,000 | 1.09% |
| KOPP INVESTMENT ADVISORS LLC | 72,755 | $2,578,000 | 0.95% |
| EMERALD ADVISERS, LLC | 455,619 | $16,143,000 | 0.91% |
| Cupps Capital Management, LLC | 254,655 | $9,022,000 | 0.58% |
| HealthCor Management, L.P. | 300,000 | $10,629,000 | 0.57% |
| EAM Investors, LLC | 79,486 | $2,816,000 | 0.56% |